Literature DB >> 16333831

Human herpesvirus 6 infection and transient acquired myelodysplasia in children.

Sandrine Kagialis-Girard1, Brigitte Durand, Valérie Mialou, Marie-Pierre Pagès, Claire Galambrun, Yves Bertrand, Claude Negrier.   

Abstract

BACKGROUND: To demonstrate that primary human herpesvirus 6 (HHV-6) infection in childhood can cause hematopoietic dysplasia that mimics a myelodysplastic syndrome (MDS) in severe cases. PROCEDURE: Seven immunocompetent children, who presented at admission with concomitant cytopenias in blood and morphologic features of dysplasia in bone marrow, were evaluated. Diagnosis of acute HHV-6 infection was secondary made by detection of HHV-6 DNA in plasma, bone marrow, or cerebrospinal fluid and measurement of plasma antibody titers. Peripheral blood and bone marrow aspirate smears were examined at diagnosis and during follow-up. Morphologic recognition of myelodysplasia was made according to the recommendations of the Third MIC Cooperative Group.
RESULTS: Anemia was the most frequent cytopenia (five of seven cases). Bi- or tri-lineage dysplasia was observed in the marrow samples. Granulocytic and erythroid cells were always affected with dysgranulopoiesis and dyserythropoiesis scores equal to or higher than 3. Myelodysplasia was not due to a clonal disorder and disappeared gradually within 1 or 2 months.
CONCLUSIONS: Our results indicate that severe HHV-6 infection may induce reversible myelodysplastic changes. These findings contribute to elucidate the pathogenicity of HHV-6 and furthermore suggest that HHV-6 infection must also be considered as a cause of dysplasia in the differential diagnosis of MDS. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16333831     DOI: 10.1002/pbc.20667

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  3 in total

1.  Donor-type myelodysplastic syndrome with t(2;3) and monosomy 7 after allogeneic peripheral blood stem cell transplantation and liver transplantation in a patient with severe-type aplastic anemia.

Authors:  Satoshi Hashino; Fumie Fujisawa; Takeshi Kondo; Masahiro Imamura; Kazuya Sato; Yoshihiro Torimoto; Yutaka Kohgo; Keisuke Kimura; Hiroyuki Furukawa; Satoru Todo; Masahiro Asaka
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 2.  Infections in myelodysplastic syndromes.

Authors:  Andréa Toma; Pierre Fenaux; François Dreyfus; Catherine Cordonnier
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

3.  Myelodysplastic syndrome in a kidney transplant recipient after SARS-CoV-2 infection: can SARS-CoV-2 induce myelodysplastic syndrome?

Authors:  Ivana Juric; Lea Katalinic; Vesna Furic-Cunko; Nikolina Basic-Jukic
Journal:  Int Urol Nephrol       Date:  2021-11-23       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.